Skip to content
Help 4 HD News Update with First HD episode artwork

Oct 8, 2013 50 min

Help 4 HD News Update with First HD

from Help 4 HD Live! Hosted by Help 4 HD Live!

PRE-RECORDED - First-HD is a Phase III clinical research trial of an investigational drug called SD-809 Extended Release (ER) in persons who have a diagnosis of Huntington disease (HD). First-HD will be enrolling participants across North America (United States and Canada) who have been diagnosed with HD and who have never taken tetrabenazine (Xenazine ®, Nitoman ®). Participants will be involved in this trial for approximately 4 months. Tonight listen to our special guests Dr. Samuel Frank - Associate Professor of Neurology and co-Director of Neurology Resident Education at Boston University and is involved with many HSG studies and trials, and David Stamler - Chief Medical Officer at Auspex Pharmaceuticals. Help 4 HD International Inc. is thrilled to be working with Auspex and HSG as their premiere communications partner.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Help 4 HD News Update with First HD

0:00 50:16

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Help 4 HD Live!?

This episode is 50 minutes long.

When was this Help 4 HD Live! episode published?

This episode was published on October 8, 2013.

Can I download this Help 4 HD Live! episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.